BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 33069797)

  • 1. Downregulation of cytokeratin 18 induces cellular partial EMT and stemness through increasing EpCAM expression in breast cancer.
    Shi R; Liu L; Wang F; He Y; Niu Y; Wang C; Zhang X; Zhang X; Zhang H; Chen M; Wang Y
    Cell Signal; 2020 Dec; 76():109810. PubMed ID: 33069797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial cell adhesion molecule promotes breast cancer resistance protein-mediated multidrug resistance in breast cancer by inducing partial epithelial-mesenchymal transition.
    Shi RZ; He YF; Wen J; Niu YN; Gao Y; Liu LH; Zhang XP; Wang Y; Zhang XL; Zhang HF; Chen M; Hu XL
    Cell Biol Int; 2021 Aug; 45(8):1644-1653. PubMed ID: 33760350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid induction on breast cancer stem cells unfolds subtype specific variations in stemness and epithelial-to-mesenchymal transition.
    Jariyal H; Gupta C; Srivastava A
    Int J Biol Macromol; 2020 Oct; 160():1078-1089. PubMed ID: 32479949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt/β-catenin pathway is required for epithelial to mesenchymal transition in CXCL12 over expressed breast cancer cells.
    Shan S; Lv Q; Zhao Y; Liu C; Sun Y; Xi K; Xiao J; Li C
    Int J Clin Exp Pathol; 2015; 8(10):12357-67. PubMed ID: 26722422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of cytokeratin 18 enhances BCRP-mediated multidrug resistance through induction of epithelial-mesenchymal transition and predicts poor prognosis in breast cancer.
    Shi R; Wang C; Fu N; Liu L; Zhu D; Wei Z; Zhang H; Xing J; Wang Y
    Oncol Rep; 2019 May; 41(5):3015-3026. PubMed ID: 30896886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia modulates stem cell properties and induces EMT through N-glycosylation of EpCAM in breast cancer cells.
    Zhang D; Yang L; Liu X; Gao J; Liu T; Yan Q; Yang X
    J Cell Physiol; 2020 Apr; 235(4):3626-3633. PubMed ID: 31584203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistin induces breast cancer cells epithelial to mesenchymal transition (EMT) and stemness through both adenylyl cyclase-associated protein 1 (CAP1)-dependent and CAP1-independent mechanisms.
    Avtanski D; Garcia A; Caraballo B; Thangeswaran P; Marin S; Bianco J; Lavi A; Poretsky L
    Cytokine; 2019 Aug; 120():155-164. PubMed ID: 31085453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FZD7 accelerates hepatic metastases in pancreatic cancer by strengthening EMT and stemness associated with TGF-β/SMAD3 signaling.
    Zhang Z; Xu Y
    Mol Med; 2022 Jul; 28(1):82. PubMed ID: 35854234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell transcriptomics reveals the intra-tumoral heterogeneity and SQSTM1/P62 and Wnt/β-catenin mediated epithelial to mesenchymal transition and stemness of triple-negative breast cancer.
    Shome R; Sen P; Sarkar S; Ghosh SS
    Exp Cell Res; 2024 May; 438(1):114032. PubMed ID: 38583856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
    Ma X; Wang B; Wang X; Luo Y; Fan W
    PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
    Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of epithelial-mesenchymal transition and inhibition of tumor stemness of breast cancer cells through advanced combined chemotherapy.
    Cui Y; Zhao M; Yang Y; Xu R; Tong L; Liang J; Zhang X; Sun Y; Fan Y
    Acta Biomater; 2022 Oct; 152():380-392. PubMed ID: 36028199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbohydrate (Chondroitin 4) Sulfotransferase-11-Mediated Induction of Epithelial-Mesenchymal Transition and Generation of Cancer Stem Cells.
    Behrens A; Jousheghany F; Yao-Borengasser A; Siegel ER; Kieber-Emmons T; Monzavi-Karbassi B
    Pharmacology; 2020; 105(5-6):246-259. PubMed ID: 32344408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated by AP1-dependent EpCAM expression in MCF-7 cells.
    Gao J; Yan Q; Wang J; Liu S; Yang X
    J Cell Physiol; 2015 Apr; 230(4):775-82. PubMed ID: 25205054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-β1 pathway affects the protein expression of many signaling pathways, markers of liver cancer stem cells, cytokeratins, and TERT in liver cancer HepG2 cells.
    Wang XH; Liu MN; Sun X; Xu CH; Liu J; Chen J; Xu RL; Li BX
    Tumour Biol; 2016 Mar; 37(3):3675-81. PubMed ID: 26462837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway.
    Xie SL; Fan S; Zhang SY; Chen WX; Li QX; Pan GK; Zhang HQ; Wang WW; Weng B; Zhang Z; Li JS; Lin ZY
    Int J Cancer; 2018 Mar; 142(6):1252-1265. PubMed ID: 29071717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of DAPK1 promotes the stemness of cancer stem cells and EMT process by activating ZEB1 in colorectal cancer.
    Yuan W; Ji J; Shu Y; Chen J; Liu S; Wu L; Zhou Z; Liu Z; Tang Q; Zhang X; Shu X
    J Mol Med (Berl); 2019 Jan; 97(1):89-102. PubMed ID: 30460377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
    Vijay GV; Zhao N; Den Hollander P; Toneff MJ; Joseph R; Pietila M; Taube JH; Sarkar TR; Ramirez-Pena E; Werden SJ; Shariati M; Gao R; Sobieski M; Stephan CC; Sphyris N; Miura N; Davies P; Chang JT; Soundararajan R; Rosen JM; Mani SA
    Breast Cancer Res; 2019 Mar; 21(1):37. PubMed ID: 30845991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer.
    Hyun KA; Koo GB; Han H; Sohn J; Choi W; Kim SI; Jung HI; Kim YS
    Oncotarget; 2016 Apr; 7(17):24677-87. PubMed ID: 27013581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional Implications of the Dynamic Regulation of EpCAM during Epithelial-to-Mesenchymal Transition.
    Brown TC; Sankpal NV; Gillanders WE
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.